Lataa...
High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
Carbohydrate antigen 19‐9 (CA19‐9) fails to demonstrate the predictive value for early detection pancreatic ductal adenocarcinoma (PDAC). Glypican‐1 (GPC1+) exosomes may serve as a noninvasive diagnostic tool to detect early stages of PDAC. Therefore, it is necessary to explore the serum GPC1 levels...
Tallennettuna:
| Julkaisussa: | Cancer Med |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6246926/ https://ncbi.nlm.nih.gov/pubmed/30358133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1833 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|